drugset / Trial / NCT07511491
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Timeline
- Start
- 2026-04-11
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 4 mg | Other |
| Subject | Ondansetron | Other / unclassified | 8 mg | Other |
Indications
No indication recorded.